Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

783
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
783
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

70
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
70
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

377
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
377

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway.

Biology direct·2026
Same author

Overexpression of β-carboxysomes increases photosynthesis and growth in Synechocystis sp. PCC 6803.

Plant physiology·2026
Same author

Genes From Epithelial-Mesenchymal Transition Predict Overall Survival Effectively in Breast Cancer: A Novel Risk Model Based on Initial Step of Tumor Metastasis.

Breast cancer : basic and clinical research·2026
Same author

M2 macrophages predict response to neoadjuvant chemotherapy in triple negative breast cancer patients.

Scientific reports·2026
Same author

Recognition of immunogenomic signature and prognostic value of the subtype of epithelial-mesenchymal transition in breast cancer.

Biochemistry and biophysics reports·2026
Same author

An Explainable Molecular Token Estimation Method for Knowledge-Aware Drug-Drug Interaction Prediction.

IEEE journal of biomedical and health informatics·2026

Related Experiment Video

Updated: Jul 6, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

DMGL-MDA: A dual-modal graph learning method for microbe-drug association prediction.

Bei Zhu1, Hao-Yang Yu1, Bing-Xue Du1

  • 1School of Life Sciences, Northwestern Polytechnical University, Xi'an 710072, China.

Methods (San Diego, Calif.)
|January 6, 2024
PubMed
Summary
This summary is machine-generated.

Identifying microbe-drug associations (MDAs) is vital for drug safety. A new computational model, dual-modal graph learning for microbe-drug association prediction (DMGL-MDA), offers a superior, cost-effective method for predicting these crucial interactions.

Keywords:
Attention networksDeep learningDual-modal embeddingLink predictionMicrobe-drug association

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

Related Experiment Videos

Last Updated: Jul 6, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

Area of Science:

  • Microbiology
  • Pharmacology
  • Computational Biology

Background:

  • Microbe-drug interactions significantly influence human health.
  • Predicting microbe-drug associations (MDAs) is essential for safe drug administration.
  • Traditional experimental methods for MDA prediction are costly and time-consuming.

Purpose of the Study:

  • To develop a novel computational approach for efficient and accurate prediction of microbe-drug associations (MDAs).
  • To overcome limitations of existing graph neural network (GNN) models, such as over-smoothing and over-squashing, and issues with similarity matrix dependency.

Main Methods:

  • Proposed a novel graph representation learning model named dual-modal graph learning for microbe-drug association prediction (DMGL-MDA).
  • DMGL-MDA incorporates a dual-modal embedding module, a bipartite graph network embedding module, and a predictor module.
  • Evaluated DMGL-MDA against state-of-the-art methods on two benchmark datasets using cross-validation.

Main Results:

  • DMGL-MDA demonstrated superior performance compared to existing methods.
  • Cross-validation confirmed the effectiveness of the proposed model.
  • Ablation experiments and case studies further validated the model's predictive capabilities.

Conclusions:

  • DMGL-MDA provides a robust and efficient computational solution for predicting microbe-drug associations.
  • The model addresses key challenges in existing GNN-based approaches, offering improved accuracy and reliability.
  • This work facilitates low-cost, high-throughput screening of potential MDAs, aiding drug development and personalized medicine.